SCHEMBL27249656

SCHEMBL27249656

Cn1cnc2c(N3CCS(=O)(=O)CC3)cccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
DDB1 Q16531 2/20 0.39
CRBN Q96SW2 2/20 0.39
HTR6 P50406 4/20 0.34
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
HTR2A P28223 5/20 0.33
DRD2 P14416 3/20 0.33
HTR2C P28335 2/20 0.33
DRD3 P35462 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
HTR1A P08908 2/20 0.33
KMT2A Q03164 2/20 0.33
CNR2 P34972 1/20 0.33
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23131531 0.85 DRD2 (0.46) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27250006 0.82 ALDH1A1 (0.60) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27250007 0.80 KDM4E (0.48) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL19297164 0.79 HTR2A (0.54) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27250002 0.79 ALDH1A1 (0.43) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27274955 0.79 TSHR (0.43) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27274921 0.78 KMT2A (0.46) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27249593 0.78 ALDH1A1 (0.52) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL27249654 0.78 ALDH1A1 (0.52) ALDH1A1KDM4EGLAGAATSHR
SCHEMBL23132005 0.77 KDM4E (0.41) ALDH1A1KDM4EGLAGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS ALDH1A1 1786/4885KDM4E 2695/4885GLA 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.